Orange Book product · Brand (NDA)
ACTOPLUS MET XR
METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE
At a glance
May 12, 2009
Approved
Brand (NDA)
Application
Not listed
TE code
2
Listed patents
Key dates
Approval
FDA approval date of this drug product.
May 12, 2009
17 yr 4 mo ago
Today
Patent 7785627 expires
Listed drug product patent expiration.
Jul 31, 2026
in 1 mo
Patent 7959946 expires
Listed drug product patent expiration.
Jul 31, 2026
in 1 mo
Pharmaceutical detail
Active ingredient
METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE
Strength
1GM;EQ 15MG BASE
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
TE code
Not listed
Application
NDA 022024
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2005ACTOPLUS METBrand (NDA)
NDA 021842 · TAKEDA PHARMS USA
- 2015PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDEGeneric (ANDA)
ANDA 204802 · MACLEODS PHARMS LTD
- 2014PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDEGeneric (ANDA)
ANDA 091155 · TEVA PHARMS USA
- 2013PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDEGeneric (ANDA)
ANDA 091273 · CHARTWELL RX
- 2013PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDEGeneric (ANDA)
ANDA 200823 · AUROBINDO PHARMA LTD
- 2013PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDEGeneric (ANDA)
ANDA 202001 · TORRENT PHARMS LTD
- 2011PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDEGeneric (ANDA)
ANDA 090406 · PHARMOBEDIENT
Listed patents (2)
| Patent | Expires | In | Type |
|---|---|---|---|
| 7785627 | Jul 31, 2026 | in 1 mo | Product |
| 7959946 | Jul 31, 2026 | in 1 mo | Product |

